SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-19-014323
Filing Date
2019-04-30
Accepted
2019-04-30 16:30:34
Documents
3
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A sbph-10ka_20181231.htm 10-K/A 736407
2 EX-31.3 sbph-ex313_6.htm EX-31.3 6029
3 EX-31.4 sbph-ex314_7.htm EX-31.4 6041
  Complete submission text file 0001564590-19-014323.txt   749512
Mailing Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748
Business Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37718 | Film No.: 19782241
SIC: 2834 Pharmaceutical Preparations